 FT MYERS, FL ACCESSWIRE March 2, 2022 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that senior management will be participating in multiple upcoming institutional investor conferences. Management will participate in investor meetings and a fireside chat at the Raymond James 43rd Annual Institutional Investors Conference in Orlando, Florida, on Monday, March 7, 2022. 